Narrow search
Showing 1 - 10 of 26,020
Cover Image
A simple model of health insurance competition
Kemnitz, Alexander - In: German economic review 14 (2013) 4, pp. 432-448
Persistent link: https://www.econbiz.de/10010194949
Cover Image
Krankenversicherung, Anreize im Gesundheitswesen und Konsumentenwohlfahrt
Anlauf, Markus - 2001
Persistent link: https://www.econbiz.de/10001559480
Cover Image
Zur Pareto-Effizienz von Krankenversicherungssystemen am Beispiel USA und Deutschland
Thomma, Thomas - In: Gesundheitssystementwicklung in den USA und Deutschland …, (pp. 121-140). 1996
Persistent link: https://www.econbiz.de/10001294395
Cover Image
Essays on the economics of selected multi-period insurance decisions with private information
Steinorth, Petra - 2011
Persistent link: https://www.econbiz.de/10009008208
Cover Image
Heterogeneous selection in the market for private supplemental dental insurance : evidence from Germany
Bauer, Jan M.; Schiller, Jörg; Schreckenberger, Christopher - In: Empirical economics : a journal of the Institute for … 59 (2020) 1, pp. 205-231
Persistent link: https://www.econbiz.de/10012253190
Cover Image
International experience with comparative effectiveness research : case studies from England
Bridges, John F. P.; Cohen, Joshua; Grist, Peter G.; … - In: Pharmaceutical markets and insurance worldwide, (pp. 29-50). 2010
Persistent link: https://www.econbiz.de/10008648707
Cover Image
Der Gesundheitsmarkt 2015 : Trends und Entwicklungen
Damm, Kathrin; Kuhlmann, Alexander; Schulenburg, … - 2010 - 1. Aufl.
Persistent link: https://www.econbiz.de/10008823283
Cover Image
Measuring access to health care services
Roll, Kathrin - 2012
Persistent link: https://www.econbiz.de/10009711603
Cover Image
Das Gesundheits-Reform-Gesetz : bleibt Baden-Württemberg ein Schwerpunkt der Pharmaforschung?
Nord, Dietrich (revision) - 1988
Persistent link: https://www.econbiz.de/10014459197
Cover Image
The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany
Dintsios, C. M.; Beinhauer, I. - In: Health economics review 10 (2020) 7, pp. 1-25
Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price negotiations after early benefit assessment between pharmaceutical companies and the German National Association of Statutory Health Insurance Funds. The analysis was conducted for...
Persistent link: https://www.econbiz.de/10012291135